NBP · NovaBridge Biosciences · Documents
Market Cap
$183.88M
Shares
115.65M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-09-08 | — | |
| 6-K | 2026-09-08 | — | |
| 6-K | 2026-08-20 | 2026-06-30 | |
| 6-K | 2026-08-20 | — | |
| 6-K | 2026-07-24 | — | |
| 6-K | 2026-07-17 | 2026-07-13 | |
| 6-K | 2026-06-29 | — | |
| 20-F/A | 2026-06-16 | 2025-12-31 | |
| 6-K | 2026-06-16 | — | |
| 6-K | 2026-06-16 | — | |
| 6-K | 2026-04-22 | — | |
| 20-F | 2026-04-07 | 2025-12-31 | |
| 6-K | 2026-04-07 | — | |
| 6-K | 2026-03-16 | — | |
| 6-K | 2026-03-09 | — | |
| 6-K | 2026-03-03 | — | |
| 6-K | 2026-02-25 | — | |
| 6-K | 2026-02-19 | — | |
| 6-K | 2026-02-17 | — | |
| 6-K/A | 2026-02-06 | — | |
| 6-K | 2026-02-06 | — | |
| 6-K | 2026-01-22 | — | |
| 6-K | 2026-01-22 | — | |
| 6-K | 2026-01-16 | — | |
| 6-K | 2026-01-06 | — | |
| 6-K | 2025-12-18 | 2025-09-30 | |
| 6-K | 2025-12-10 | — | |
| 6-K | 2025-12-04 | 2025-12-03 | |
| 6-K | 2025-10-31 | — | |
| 6-K | 2025-10-30 | 2025-10-29 | |
| 6-K | 2025-10-29 | — | |
| 6-K | 2025-10-28 | — | |
| 6-K | 2025-10-24 | — | |
| 6-K | 2025-10-24 | — | |
| 6-K/A | 2025-10-24 | — | |
| 6-K | 2025-10-23 | — | |
| 6-K | 2025-10-22 | — | |
| 6-K | 2025-10-16 | — | |
| 6-K | 2025-10-06 | 2025-06-30 | |
| 6-K | 2025-09-24 | — | |
| 6-K | 2025-09-08 | 2025-09-03 | |
| 6-K | 2025-08-25 | 2025-08-22 | |
| 6-K | 2025-08-20 | — | |
| 6-K | 2025-08-11 | — | |
| 6-K | 2025-08-04 | — | |
| 6-K | 2025-08-01 | — | |
| 6-K | 2025-07-17 | — | |
| 6-K | 2025-07-11 | — | |
| 6-K/A | 2025-07-11 | — | |
| 6-K | 2025-07-02 | — |
Showing 1–50 of 176 filings